Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-005529

President and CEO acquired 15,450 shares (option exercise)

  • President and CEO gave up 5,343 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Culley Brian M President and CEO 2020-03-31 Option exercise +15,450 $0.83 $12,794 160,624 D: show line 1 in the form
Culley Brian M President and CEO 2020-03-31 Shares withheld for taxes −5,343 $0.83 $4,425 155,281 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Culley Brian M President and CEO 2020-03-31 Option exercise · Restricted Stock Units −15,450 139,050 D: show line 3 in the form
Loading xslF345X03/ownership.xml…